These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14671866)

  • 1. Pharma focus. Saints and sinners.
    Lewis C
    Health Serv J; 2003 Nov; 113(5883):suppl 5. PubMed ID: 14671866
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharma focus. Market traders.
    Lewis C
    Health Serv J; 2003 Nov; 113(5883):suppl 2-3. PubMed ID: 14671865
    [No Abstract]   [Full Text] [Related]  

  • 3. NHS joint working with industry is out of public sight.
    Moberly T
    BMJ; 2019 Mar; 364():l1353. PubMed ID: 30917947
    [No Abstract]   [Full Text] [Related]  

  • 4. Disease management and the drug industry: carve out or carve up?
    Burns H
    Lancet; 1996 Apr; 347(9007):1021-3. PubMed ID: 8606567
    [No Abstract]   [Full Text] [Related]  

  • 5. Which way now for the Cancer Drugs Fund?
    Jack A
    BMJ; 2014 Sep; 349():g5524. PubMed ID: 25204283
    [No Abstract]   [Full Text] [Related]  

  • 6. We can change the way we develop and fund drugs.
    Radcliffe M
    Nurs Times; 2009 Jun; 105(23):32. PubMed ID: 19624056
    [No Abstract]   [Full Text] [Related]  

  • 7. Five cancer drugs back on NHS list after deals with drug companies.
    Hawkes N
    BMJ; 2015 Nov; 351():h5985. PubMed ID: 26546283
    [No Abstract]   [Full Text] [Related]  

  • 8. Good pharma, bad pharma.
    Drug Ther Bull; 2013 Aug; 51(8):85. PubMed ID: 23927857
    [No Abstract]   [Full Text] [Related]  

  • 9. Waiving the rules.
    Taylor D
    Health Serv J; 1992 Jun; 102(5305):20-2. PubMed ID: 10171042
    [No Abstract]   [Full Text] [Related]  

  • 10. Joint working. A dose of partnership.
    Moore A
    Health Serv J; 2012 Nov; 122(6329):Suppl 6-7. PubMed ID: 23488347
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulating the pharmaceutical industry. Regulation may no longer be necessary.
    Rowlatt P
    BMJ; 1998 Jan; 316(7126):227; author reply 228. PubMed ID: 9468702
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceutical industry guide. The chosen few.
    Watts G
    Health Serv J; 2002 Nov; 112(5833):suppl 10-1. PubMed ID: 12478711
    [No Abstract]   [Full Text] [Related]  

  • 13. One year to save the NHS--what would you do?
    Kmietowicz Z
    BMJ; 2007 Jan; 334(7586):180-1. PubMed ID: 17255607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes to the regulation of drug prices in the UK.
    Collier J
    BMJ; 2008 Dec; 337():a2735. PubMed ID: 19114449
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmaceutical industry guide. Bitter pills.
    Bryan J
    Health Serv J; 2002 Nov; 112(5833):suppl 1-3. PubMed ID: 12478709
    [No Abstract]   [Full Text] [Related]  

  • 16. NHS spending on drugs is frozen for two years under price deal.
    Wise J
    BMJ; 2013 Nov; 347():f6731. PubMed ID: 24201064
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulating the pharmaceutical industry. Authors seem to have misunderstood pharmaceutical price regulation scheme.
    Read P
    BMJ; 1998 Jan; 316(7126):226; author reply 228. PubMed ID: 9468700
    [No Abstract]   [Full Text] [Related]  

  • 18. Social insurance--the right way forward for health care in the United Kingdom? For.
    Irvine B; Green DG
    BMJ; 2002 Aug; 325(7362):488-90. PubMed ID: 12202334
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmaceutical industry guide. Strange bedfellows?
    Moore A
    Health Serv J; 2002 Nov; 112(5833):suppl 13-5. PubMed ID: 12478712
    [No Abstract]   [Full Text] [Related]  

  • 20. General practice under pressure.
    Meldrum H
    BMJ; 2006 Jan; 332(7532):46-7. PubMed ID: 16399742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.